Study reports on a 14-year-old boy with atopic dermatitis who experienced complete symptom resolution after combining monoclonal antibody treatment with a Mediterranean diet. Highlighting the role of diet in managing inflammatory skin conditions, the case study suggests the therapeutic potential of integrating dietary changes with medical treatment for improved outcomes.
Exelixis cuts 175 staffers to prioritize late-stage drug development
Exelixis is laying off 175 employees, or 13% of its workforce, to “rebalance resources” with a focus on candidates closer to market. The company appears
January 9, 2024